NanoBlu Per bottle
$ 106.00
Studies have concluded the combination of Red-Light Therapy along with sublingual and/or nebulization of Liposomal Methylene Blue has shown to prevent and reduce the effects...
Studies have concluded the combination of Red-Light Therapy along with sublingual and/or nebulization of Liposomal Methylene Blue has shown to prevent and reduce the effects of COVID-19 and the Post Viral Syndrome, also known as the Long Haulers Syndrome. Recent research has shown that methylene blue may be neuroprotective against several cytotoxicity related diseases such as stroke and Parkinson’s disease to include High blood pressure as well. Methylene blue is an electron carrier, which allows it to function against malaria and methemoglobinemia, and is highly beneficial in cytotoxic situations in the brain as in cardiac tissue, it encourages cellular oxygen consumption and decreases anaerobic glycolysis.
These benefits are highly relevant to conditions such as Alzheimer’s disease, Parkinson’s disease and stroke. Direct comparisons to antipsychotic drugs, such as phenothiazine, showed that methylene blue has similar neuroprotective effects, but a different mechanism.
Studies have also showed enhanced improvements with the combination of red-light therapy and Liposomal Methylene Blue include:
*Decreases the infection process of COVID-19 and protects and decreases the Post Viral Syndromes.
*Aids in respiratory illnesses like flu viruses and allergies as in asthma and rhinitis.